Express Pharma

Pfizer to buy Array Biopharma for $10.64 bn in cash


Array is Pfizer’s first major purchase under new Chief Executive Albert Bourla, who took on the role in January

Pfizer will buy Array Biopharma for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.

The US drugmaker agreed to pay a hefty premium of 62 per cent for Array, which sells the combination treatment Braftovi and Mektovi for melanoma. But those drugs appear po